Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Goodwill (2024 - 2025)

Updated

Sinovac Biotech (SVA) reported Goodwill of $12.6 million for Q4 2025, down 54.2% from $27.51 million a year earlier.

Analysis

Sinovac Biotech (SVA) Goodwill (2024 - 2025) Analysis & Trends

  • By year, Goodwill came in at $27.51 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,166.82 Bn 1,135.41 Bn 19.71 Bn
2 Johnson & Johnson 644.52 Bn 564.38 Bn 17.30 Bn
3 AbbVie 501.88 Bn 474.99 Bn 12.70 Bn
4 Merck 358.72 Bn 313.10 Bn 12.21 Bn
5 Novartis Ag 302.27 Bn 266.26 Bn 11.24 Bn
6 Astrazeneca 267.62 Bn 241.31 Bn 12.86 Bn
7 Amgen 241.67 Bn 197.07 Bn 7.24 Bn
8 Gilead Sciences 193.09 Bn 167.28 Bn 6.22 Bn
9 Pfizer 171.60 Bn 118.24 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 12.60 Mn
Dec 31, 2024 27.51 Mn
API Access

Sinovac Biotech Goodwill API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill&ticker=SVA&period=max&api_key=YOUR_API_KEY